Showing results (31-40 of 172) with videos related to
Sort By:
Pageof 18
BMC Cancer|May 13, 2010
Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathwayKeinosuke Ryu, Michiro Susa, Edwin Choy, et al.Plos One|September 11, 2009
ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell linesZhenfeng Duan, Edwin Choy, David Harmon, et al.Spine|April 14, 2010
Blockage of Stat3 with CDDO-Me inhibits tumor cell growth in chordomaCao Yang, Francis J Hornicek, Kirkham B Wood, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|March 10, 2011
ROCK1 as a potential therapeutic target in osteosarcomaXianzhe Liu, Edwin Choy, Francis J Hornicek, et al.Molecular Cancer Therapeutics|July 30, 2009
Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell linesZhenfeng Duan, Edwin Choy, David Harmon, et al.Molecular Cancer Therapeutics|May 22, 2016
Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to PaclitaxelXianzhe Liu, Yan Gao, Jacson Shen, et al.Scientific Reports|May 10, 2016
Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and ratsYan Gao, Jacson K Shen, Edwin Choy, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 2, 2017
CDK4 expression in chordoma: A potential therapeutic targetTang Liu, Jacson K Shen, Edwin Choy, et al.Spine|June 3, 2016
Frequency and Risk Factors for Additional Lesions in the Axial Spine in Subjects With Chordoma: Indications for ScreeningRonnie Sebro, Thomas F DeLaney, Francis Hornicek, et al.Molecular Cancer Therapeutics|August 9, 2008
Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancerZhenfeng Duan, Edward J Weinstein, Diana Ji, et al.Pageof 18